FTBlogs: Chinese pharma cracks down on African counterfeits
The reputation of Chinese pharmaceuticals in Africa has taken a hammering over the last couple of years. Far from curing disease, Chinese companies are accused of sitting at the centre of a vast counterfeiting industry dumping fake medicines on the continent at a cost of billions of dollars and countless lives. But two Chinese pharmaceutical companies – Guilin Pharmaceuticals and Watson Global Pharmaceuticals – are breaking new ground by introducing SMS-based authenticity checks for their anti-malarial drugs in Africa.
